Mahmood, ShehrozMorrice, NicolaThompson, DawnMilanizadeh, SaraWilson, SophieWhitfield, Philip DMcIlroy, George DavidRochford, JustinMody, Nimesh2025-04-232025-04-232025-08-01Mahmood, S, Morrice, N, Thompson, D, Milanizadeh, S, Wilson, S, Whitfield, P D, McIlroy, G D, Rochford, J & Mody, N 2025, 'Hydroxysteroid 17-beta dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice', Experimental Physiology, vol. 110, no. 8, pp. 1071-1086. https://doi.org/10.1113/EP0925350958-0670ORCID: /0000-0003-0948-9458/work/179299846ORCID: /0000-0003-4230-4355/work/179300431ORCID: /0000-0002-5020-4939/work/179300671ORCID: /0000-0002-2215-7952/work/179300695https://hdl.handle.net/2164/25355Open access via Wiley agreement This article was first published as a preprint. Mahmood S, Morrice N, Thompson D, Milanizadeh S, Wilson S, Whitfield PD, Mcilroy GD, Rochford JJ, Mody N. 2024. Hydroxysteroid 17-beta dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice. bioRxiv. https://doi.org/10.1101/2024.02.27.582262161369473engSubstantive connection via an eligible employment contractSDG 3 - Good Health and Well-beingfenretinidefibrosishydroxysteroid 17β‐dehydrogenase 13 (Hsd17b13)metabolic dysfunction‐associated steatotic liver disease (MASLD)phospholipidsR Medicine (General)Supplementary DataDASR1Journal article10.1113/EP0925351108